Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 672.96K | 97.63K | 0.00 | 257.03K | 4.60K |
Gross Profit | 672.96K | 96.28K | -212.00 | 164.31K | 4.60K |
EBITDA | -788.00K | -1.14M | -929.00K | -517.00K | -20.25K |
Net Income | -644.00K | -1.50M | -1.18M | -90.78K | -133.74K |
Balance Sheet | |||||
Total Assets | 2.72M | 2.68M | 3.48M | 3.82M | 288.18K |
Cash, Cash Equivalents and Short-Term Investments | 366.97K | 425.00K | 1.38M | 2.07M | 28.14K |
Total Debt | 417.01K | 0.00 | 0.00 | 150.22K | 46.46K |
Total Liabilities | 584.89K | 201.79K | 203.99K | 121.92K | 169.30K |
Stockholders Equity | 2.14M | 2.48M | 3.27M | 3.70M | 118.87K |
Cash Flow | |||||
Free Cash Flow | -606.38K | -1.24M | -753.93K | -498.38K | -193.88K |
Operating Cash Flow | -603.11K | -1.24M | -750.76K | -498.38K | -193.88K |
Investing Cash Flow | -51.81K | -413.74K | -579.61K | -1.06M | -260.00K |
Financing Cash Flow | 596.89K | 700.00K | 635.00K | 3.60M | 447.95K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
61 Neutral | $10.07B | 6.27 | 0.67% | 3.01% | 2.91% | -45.05% | |
48 Neutral | $91.53M | ― | -15.37% | ― | ― | -34.41% | |
45 Neutral | AU$6.03M | ― | -65.64% | ― | ― | -35.00% | |
44 Neutral | €141.55M | ― | ― | ― | ― | ||
42 Neutral | AU$17.87M | ― | -141.00% | ― | 37.21% | 4.76% | |
37 Underperform | AU$26.91M | ― | -15.00% | ― | ― | 13.33% | |
35 Underperform | AU$77.65M | ― | -27.89% | ― | ― | 55.31% |
Papyrus Australia Ltd has revised its March 2025 Quarterly Appendix 4C report to correct the treatment of R&D expenditure initially reported as a cash transaction. The revision follows discussions with auditors, revealing that the expenditure should have been treated as a non-cash transaction, impacting previously reported cash flow figures. This correction affects several financial reports from December 2024 to March 2025, highlighting the company’s commitment to accurate financial reporting and transparency.
Papyrus Australia Ltd has signed a contract with the University of South Australia to establish a Rapid Prototyping and R&D Facility in Adelaide. This collaboration aims to enhance Papyrus’s technological capabilities and expedite the development of their Phase 2 Technology, focusing on sustainable materials for food-grade packaging and other applications. The partnership underscores Papyrus’s commitment to innovation and sustainability, leveraging UniSA’s resources to expand their product range and meet the growing demand for eco-friendly materials.
Papyrus Australia Ltd has made significant advancements in its commercialisation projects during the first quarter of 2025. The company strengthened its joint venture with Thung Dung Co. in Vietnam, confirming favorable conditions for a facility that will convert banana plantation waste into sustainable products. In Australia, Papyrus is progressing with the development of a Rapid Prototyping and R&D facility, crucial for short-term revenue generation. The company has raised $200k to support these initiatives, demonstrating strong shareholder support and disciplined cost management as it moves toward achieving commercial outcomes.
Papyrus Australia Ltd’s recent quarterly cash flow report indicates a challenging period with a net cash outflow from operating activities of $685,000 for the current quarter. Despite this, the company managed to achieve a net cash inflow from investing activities of $483,000 and secured $200,000 from financing activities. This financial maneuvering reflects the company’s efforts to stabilize its cash position amidst ongoing operational expenses and investments in sustainable product development.
Papyrus Australia Ltd has reported significant progress in its commercialisation efforts, particularly in the areas of feasibility work for a joint venture in Vietnam and the prototyping of banana fibre boards for flat product applications. The company has also ordered major equipment for its Rapid Prototyping and R&D Facility in Adelaide, which will support the accelerated development of commercially viable products. These advancements are part of Papyrus’s strategic roadmap to expand its global footprint and enhance its market positioning in the sustainable materials industry.
Papyrus Australia Ltd reported its cash flow activities for February 2025, highlighting a net cash outflow from operating activities amounting to $570,000, primarily due to research and development, product manufacturing, and staff costs. However, the company experienced a positive cash flow from investing activities, totaling $489,000, driven by cash inflows from loans to other entities. The overall cash position improved with a net increase in cash and cash equivalents of $343,000 for the period, indicating a strategic focus on managing financial resources effectively.
Papyrus Australia Ltd announced the successful conversion of unlisted options by its Chairman, Al Jawhari, raising $50,000. This funding will be allocated towards research and development as well as commercial activities, potentially enhancing the company’s operational capabilities and market position in sustainable packaging and agricultural products.
Papyrus Australia Ltd has announced the issuance of 5,000,000 fully paid ordinary shares without disclosure to investors under the Corporations Act 2001. This move indicates the company’s compliance with relevant provisions of the Act and suggests a strategic financial maneuver to potentially enhance its capital structure.
Papyrus Australia Ltd has announced the quotation of 5,000,000 ordinary fully paid securities on the ASX, effective March 18, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and provide additional capital for its operations, potentially benefiting stakeholders by strengthening its position in the sustainable materials sector.
Papyrus Egypt LLC has released its half-year financial report for the period ending December 31, 2024. The report includes comprehensive financial statements, providing insights into the company’s financial health and operational performance. This release is crucial for stakeholders as it offers a detailed view of the company’s financial position, which can impact future business decisions and strategies.
Papyrus Australia Ltd reported significant progress in January 2025, including feasibility work for a joint venture in Vietnam and the consolidation of its Egyptian operations. The company raised $150,000 to support commercialization efforts and began designing scaled-up equipment prototypes for its phase 2 technology. Initial discussions for production facilities in South America and the Middle East indicate potential expansion opportunities. Financially, Papyrus completed a small capital raise and reported expenditures primarily related to staff, legal, and compliance costs.
Papyrus Australia Ltd’s latest cash flow report reveals a net cash increase of $266,000 for January 2025, contributing to a total increase of $519,000 over the past seven months. The company experienced a net cash outflow from operating activities, primarily due to research and development and staff costs, but this was offset by cash inflows from government grants and tax incentives. Investing activities remained stable, with no significant cash outflows or inflows, while financing activities saw a positive cash flow due to proceeds from equity securities and borrowings. This financial performance highlights Papyrus Australia’s strategic focus on maintaining liquidity while investing in sustainable growth initiatives.
Papyrus Australia Ltd reported a significant increase in its loss for the half-year ending December 31, 2024, with a 344% rise compared to the previous year. The company did not declare any dividends for the period, and its net tangible assets per security decreased from 0.005 to 0.003 cents, indicating a challenging financial period for the company.